GPP

Great Point Partners Portfolio holdings

AUM $308M
1-Year Est. Return 183.85%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+183.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$520M
AUM Growth
+$63.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
46
New
Increased
Reduced
Closed

Top Buys

1
+$33.5M
2
+$17M
3
+$15M
4
PCRX icon
Pacira BioSciences
PCRX
+$13.9M
5
RNAC icon
Cartesian Therapeutics
RNAC
+$13.8M

Top Sells

1
+$24.9M
2
+$15.2M
3
+$10.7M
4
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$10.4M
5
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$7.34M

Sector Composition

1 Healthcare 84.97%
2 Technology 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$3.86M 0.74%
40,890
-3,049
27
$2.9M 0.56%
247,899
-159,660
28
$2.55M 0.49%
4,127,232
29
$1.24M 0.24%
+169,014
30
$835K 0.16%
637,279
31
$761K 0.15%
+1,374
32
$139K 0.03%
8,676
-1,431
33
– –
-1,000,000
34
– –
-25,000
35
– –
-69,205
36
– –
-122,129
37
– –
0
38
– –
-541
39
– –
0
40
– –
-539,571
41
– –
0
42
– –
0
43
– –
-155,265
44
– –
0
45
– –
-200,000
46
– –
-377,900
1
2